International Journal of Medical and All Body Health Research  |  e-ISSN: 2582-8940  |  Double-Blind Peer Review  |  Open Access  |  CC BY-NC-SA 4.0

Current Issues
     2026:7/4

International Journal of Medical and All Body Health Research

e-ISSN: 2582-8940 | Open Access

Epidemiology of breast Cancer in Africa: Incidence, Prevalence and Dermographic Variables

Azuonwu Goodluck, Masa Happiness P

Department of Nursing Sciences, University of Port Harcourt, Nigeria; Department of Human Kinetics Health and Safety Studies, Ignatius Ajuru Unversity, Nigeria

Article Information

Volume / Issue3 / 3 (July-September 2022)
Pages01-07
AccessOpen Access

Publication Timeline

  • Received28 May 2021
  • Accepted13 June 2021

Full Text (PDF)

Open Access - Free to Download

Download Full Article (PDF) JATS XML

Abstract

Breast cancer is the most frequent form of cancer in women and the most common cancer in women overall. Every year, more than one million women are diagnosed with breast cancer. Worldwide, breast cancer is a leading cause of cancer-related mortality in women, and this is no exception among Nigerian women. However, in most African countries, there is a lack of information about the prevalence of breast cancer in females. Breast cancer incidence is thought to be influenced by a number of demographic factors. Among them are factors such as age, marital status, sex, age at menarche, age at first full-term pregnancy, parity, breastfeeding, age at menopause, obesity, and level of physical activity, to name just a few of the most important.. It was decided to carry out a comprehensive search of the internet, including Medline, EMBASE, Global Health, and African Journals Online (AJOL). In addition, the analysis incorporated breast cancer registry studies undertaken in Africa, which provided estimates of the crude incidence of breast cancer among women in the community. In Africa, the evidence points to an increasing prevalence of breast cancer.

Keywords

EpidemiologyBreast cancerAfrica

References

  1. Abanobi, Ewuzie. Attitude and Practice of Health Care Professionals, Regarding HIV and AIDS in Abia State Hospitals, 2016. [Google Scholar][Crossref]
  2. Adebamowo SN, Ajayi IO. Consumption of processed food dietary patterns in four African populations. Public Health Nutrition. 2018; 21(8):1529-1537. [Google Scholar][Crossref]
  3. Al-Nagger, Al-Gburi AS, Alwan NA. Correlation International Journal of Medical and All Body Health Research www.allmedicaljournal.com between breast self-examination practices and demographic characteristics, risk factors and clinical stage of breast cancer among Iraqi patients. Open access Macedonian journal of medical sciences . 2019; 7(19):3216. [Google Scholar][Crossref]
  4. American Cancer Society. The histological subtypes of breast cancer seen in a tertiary hospital in South-East, Nigeria. Glob J Health Sci. 2007;12(6):93. [Google Scholar][Crossref]
  5. American Cancer Society. Cancer screening in the United States, 2019: A review of current American Cancer Society guidelines and current issues in cancer screening. CA: a cancer journal for clinicians. 2019; 69(3):184-210. [Google Scholar][Crossref]
  6. American Cancer Society. Codelivery of an optimal drug/siRNA combination using mesoporous silica nanoparticles to overcome drug resistance in breast cancer in vitro and in vivo. ACS nano. 2013; 7(2):994-1005. [Google Scholar][Crossref]
  7. Balekouzou A, Yin P, Pamatika CM, Bishwajit G, Nambei SW, Djeintote M, Koffi B. Epidemiology of breast cancer: retrospective study in the Central African Republic. BMC Public Health. 2016; 16(1):1-10. [Google Scholar][Crossref]
  8. Baum GP, Cook ED, Sutherland EI, Schover LR, Newman LL. Missing documentation in breast cancer survivors: genitourinary syndrome of menopause. Menopause. 2017; 24(12):1360. [Google Scholar][Crossref]
  9. Bowen RL, Duffy SW, Ryan DA, Hart IR, Jones JL. Early onset of breast cancer in a group of British black women. British journal of cancer. 2008; 98(2):277-281. [Google Scholar][Crossref]
  10. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.cancer journal for clinicians. 2018; 68(6):394-424. [Google Scholar][Crossref]
  11. Bryan AD. Performance of breast self-exam: An interaction with age. Journal of Prevention & Intervention in the Community. 2001; 22(2):7-22. [Google Scholar][Crossref]
  12. Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, Millikan RC. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. 2006; 295(21):2492, 2502. [Google Scholar][Crossref]
  13. Champion VL, Wagner LI, Monahan PO, Daggy J, Smith L, Cohee A, Sledge Jr GW. Comparison of younger and older breast cancer survivors and age‐ matched controls on specific and overall quality of life domains. Cancer. 2014; 120(15):2237-2246. [Google Scholar][Crossref]
  14. Chen VW, Correa P, Kurman RJ, Wu XC, Eley JW, Austin D, Sobhan M. Histological characteristics of breast carcinoma in blacks and whites. Cancer Epidemiology and Prevention Biomarkers . 1994; 3(2):127-135. [Google Scholar][Crossref]
  15. Clegg-Lamptey JN. Epidemiology of breast cancer in Africa. Accra - School of Medicine and Dentistry, University of Ghana. Couns. 2018; 100(1):167-73. [Google Scholar][Crossref]
  16. D'agincourt-Canning L. Genetic testing for hereditary breast and ovarian cancer: Responsibility and choice. Qualitative Health Research. 2006; 16(1):97-118. [Google Scholar][Crossref]
  17. Dickens C, Joffe M, Jacobson J, Venter F, Schüz J, Cubasch H, McCormack V. Stage at breast cancer diagnosis and distance from diagnostic hospital in a periurban setting: a South African public hospital case series of over 1,000 women. International journal of cancer. 2014; 135(9):2173-2182. [Google Scholar][Crossref]
  18. Dündar G, Tarı Selçuk K, Avcı D, Yılmaz Mercan Y. Breast cancer screening behaviors in women aged 40 years and over in a semi-urban region in Turkey: relationships with health beliefs. In Healthcare. 2020; 8(2):171. [Google Scholar][Crossref]
  19. Dunn J, Boulding T, McCuaig RD, Tan A, Hardy K, Wu F, Rao S. LSD1 activation promotes inducible EMT programs and modulates the tumour microenvironment in breast cancer. Scientific reports. 2018; 8(1):1-18. [Google Scholar][Crossref]
  20. Enow Orock GE, Ndom P, Doh AS. Current cancer incidence and trends in Yaounde, Cameroon. Oncol Gastroenterol Hepatol Reports. 2012; 1(1):58-63. [Google Scholar][Crossref]
  21. Fancher TT, Palesty JA, Paszkowiak JJ, Kiran RP, Malkan AD, Dudrick SJ. Can breast self-examination continue to be touted justifiably as an optional practice?. International journal of surgical oncology, 2011. [Google Scholar][Crossref]
  22. Ferlay HR, Shin F Bray, D Forman, C Mathers, DM Parkin. 2010). GLOBOCAN 2008 Cancer incidence and mortality world-wide: IARC Cancer Base No. 10. http://globocan. [Google Scholar][Crossref]
  23. Forman D, Bray F, Brewster DH, Gombe Mbalawa C, Kohler B, Piñeros M, Ferlay J. Cancer incidence in five continents, Vol. X. IARC scientific publication, 2013, 164. [Google Scholar][Crossref]
  24. George AM. Targeted sequencing of BRCA1 and BRCA2 across a large unselected breast cancer cohort suggests that one-third of mutations are somatic. Annals of Oncology. 2016; 27(8):1532-1538. [Google Scholar][Crossref]
  25. Global cancer facts and figures. (2018) .GLOBOCAN, 3rd edition [Google Scholar][Crossref]
  26. Grover S, Martei YM, Puri P, Prabhakar P, Mutebi M, Balogun OD, Zetola NM. Breast cancer and HIV in Sub-Saharan Africa: a complex relationship. Journal of Global Oncology. 2017; 4:1-11. [Google Scholar][Crossref]
  27. Hayes DF. 20-year risks of breast-cancer recurrence after stopping endocrine therapy at 5 years. New England Journal of Medicine. 2017; 377(19):1836-1846. [Google Scholar][Crossref]
  28. Ikechukwu C, Nnenna L, Nwimo IO, Onwunaka C. Breast cancer knowledge among women in Ebonyi state, Nigeria: Implication for women breast cancer education. Journal of Health Education Research & Development, 2015. [Google Scholar][Crossref]
  29. Irurhe Al-Sharbatti SS, Shaikh RB, Mathew E, Al-Biate MAS. Breast self examination practice and breast cancer risk perception among female university students in Ajman. Asian Pacific Journal of Cancer Prevention. 2013; 14(8):4919-4923. [Google Scholar][Crossref]
  30. Jemal A, Bray F, Forman D, O'Brien M, Ferlay J, Center M, Parkin DM. Cancer burden in Africa and opportunities for prevention. Cancer. 2012; 118(18):4372-4384. [Google Scholar][Crossref]
  31. Johnson and Dickson-Swifta. Knowledge, attitude and acceptance of bilateral prophylactic mastectomy among female staff in a private university in Nigeria, 2018. [Google Scholar][Crossref]
  32. Juon, Seo and Kim. Effectiveness of an ongoing, community-based breast cancer prevention program for Korean American women. Health & Social Work, 2016; 41(1):51-59. [Google Scholar][Crossref]
  33. Katz SJ. Cancer care delivery research and the National Cancer Institute SEER Program: challenges and opportunities. JAMA oncology. 2015; 1(5):677-678. [Google Scholar][Crossref]
  34. Kendra. Skin cancer screening: recommendations for data-driven screening guidelines and a review of the US International Journal of Medical and All Body Health Research www.allmedicaljournal.com Preventive Services Task Force controversy. Melanoma management. 2017; 4(1):13-37. [Google Scholar][Crossref]
  35. Khalijah Hanafiah. Microarray Data Classification to Detect Cancer Cells by Using Discrete Wavelet Transform and Combining Classifiers Methods. In 2020 International Conference on Data Science and Its Applications, 2019, 1-7. [Google Scholar][Crossref]
  36. Kohler RE, Gopal S, Miller AR, Lee CN, Reeve BB, Weiner BJ, Wheeler SB. A framework for improving early detection of breast cancer in sub-Saharan Africa: A qualitative study of help seeking behaviors among Malawian women. Patient education and counseling. 2017; 100(1):167-173. [Google Scholar][Crossref]
  37. Lancet. Menopausal hormones: definitive evidence for breast cancer. The Lancet. 2019; 394(10204):1116-1118. [Google Scholar][Crossref]
  38. Lawal KA, Adelusola MA Durosimi. The severity, outcome and challenges of breast cancer in Nigeria. The breast. 2016; 15(3):399-409. [Google Scholar][Crossref]
  39. Legg, Fauber, Ozcan. The use of mammography by survivors of breast cancer. American journal of public health. 2017; 88(11):1713-1714. [Google Scholar][Crossref]
  40. Leszczynska A, Mesquida M, Llorenç V, Adán A. Interleukin-6 blockade in ocular inflammatory diseases. Clinical & Experimental Immunology. 2014; 176(3):301-309. [Google Scholar][Crossref]
  41. Lewis MT. Patient-derived xenograft models of breast cancer and their predictive power. Breast cancer research. 2015; 17(1):1-13. [Google Scholar][Crossref]
  42. Macheneri. Breast cancer exosome-like microvesicles and salivary gland cells interplay alters salivary gland cell-derived exosome-like microvesicles in vitro. PloS one. 2012; 7(3). [Google Scholar][Crossref]
  43. Mcmillan Johnson, Ojeda. Relief of symptoms, side effects, and psychological distress through use of complementary and alternative medicine in women with breast cancer, 2016. [Google Scholar][Crossref]
  44. Mehrnoosh Al-Dubai, Ganasegeran SAR, Alabsi KM, Manaf MRA, Ijaz S, Kassim S. Exploration of barriers to breast-self examination among urban women in Shah Alam, Malaysia: a cross sectional study. Asian Pacific Journal of Cancer Prevention. 2012; 13(4):1627-1632. [Google Scholar][Crossref]
  45. Millat WA. Knowledge of secondary-school female students on breast cancer and breast self-examination in Jeddah, Saudi Arabia. EMHJ-Eastern Mediterranean Health Journal. 2000; 6(2-3):338-344. [Google Scholar][Crossref]
  46. Muchiri. Narrative Persuasion: Moderating effects of character identification on relationship between message format and intention to screen for cervical cancer among women in agricultural sector in Kiambu County, Kenya. Journal of Development and Communication Studies. 2016; 8(1):164-184. [Google Scholar][Crossref]
  47. Mutebi M, Edge J. Stigma, survivorship and solutions: Addressing the challenges of living with breast cancer in low-resource areas. South African Medical Journal . 2014; 104(5). [Google Scholar][Crossref]
  48. Oluwatosin OA. Rural women's perception of breast cancer and its early-detection measures in Ibadan, Nigeria. Cancer nursing. 2006; 29(6):461-466. [Google Scholar][Crossref]
  49. Omaka-Amari LN, Ilo CI, Nwimo IO, Onwunaka C, Umoke CI. Demographic differences in the knowledge of breast cancer among women in Ebonyi State, Nigeria. IJNMH. 2015; 1(3):18-27. [Google Scholar][Crossref]
  50. Omolase C, Akinwalere A, Omotayo R, Omolase B, Elekwachi G, Majekodunmi M. Bilateral Ectopia Lentis in Marfan’s syndrome: a case Report. Clin Surg. 2018; 3:2244. [Google Scholar][Crossref]
  51. Otieno ES, Micheni JN, Kimende SK, Mutai KK. Provider d elay in the diagnosis and initiation of definitive treatment for breast cancer patients. East African Medical Journal. 2020; 87(4):143-146. [Google Scholar][Crossref]
  52. Paul, Barrat, Redman, Cockburn, Lowe. Breast self-examination and death from breast cancer: a meta-analysis. British journal of cancer. 2019; 88(7):1047-1053. [Google Scholar][Crossref]
  53. Petro-Naustas. The value of routine screening mammography in women aged 35–39 years in a symptomatic breast unit. Clinical Radiology. 2016; 72(6):517-e7. [Google Scholar][Crossref]
  54. Phillips, Wilbur. Breast cancer survivors’ preferences for technology-supported exercise interventions. Supportive Care in Cancer. 2015; 25(10):3243-3252. [Google Scholar][Crossref]
  55. Phumla. Using health belief model to probe female adolescent perception about breast cancer in Riyadh city. American Journal of Nursing Science. 2016; 6(4):358-365. [Google Scholar][Crossref]
  56. Rasul A, Riaz A, Hussain G, Zubair M, Samiullah K, Sarfraz I, Sultana S. Eriocalyxin B induces apoptosis in human triple negative breast cancer cells via inhibiting STAT3 activation and mitochondrial dysfunction. Pakistan Journal of Pharmaceutical Sciences. 2019; 32(6 (Supplementary)):2843-2848. [Google Scholar][Crossref]
  57. Rayne S, Schnippel K, Firnhaber C, Wright K, Kruger D, Benn CA. Fear of treatments surpasses demographic and socioeconomic factors in affecting patients with breast cancer in urban South Africa. Journal of Global Oncology. 2017; 3(2):125-134. [Google Scholar][Crossref]
  58. Reddy P, Ebrahim S, Ramklass S, Buccimazza I. Breast Cancer and HIV: a South African perspective and a critical review of the literature. South African Journal of Surgery. 2017; 55(1):10-15. [Google Scholar][Crossref]
  59. Sariego. Disparity in breast cancer late stage at diagnosis in Missouri: does rural versus urban residence matter?. Journal of racial and ethnic health disparities. 2016; 3(2):233-239. [Google Scholar][Crossref]
  60. Shulman LN, Pace LE. Breast cancer in sub‐Saharan Africa: Challenges and opportunities to reduce mortality. The oncologist. 2016; 21(6):739-744. [Google Scholar][Crossref]
  61. Surbhi S, Munshi KD, Bell PC, Bailey JE. Drug therapy problems and medication discrepancies during care transitions in super-utilizers. Journal of the American Pharmacists Association. 2016; 56(6):633-642. [Google Scholar][Crossref]
  62. Tabrizi FM, Vahdati S, Khanahmadi S, Barjasteh S. Determinants of breast cancer screening by mammography in women referred to health centers of Urmia, Iran. Asian Pacific journal of cancer prevention: APJCP. 2018; 19(4):997. [Google Scholar][Crossref]
  63. Thomas AS, Kidwell KM, Oppong JK, Adjei EK, Osei-Bonsu E, Boahene A, Merajver SD. Breast cancer in Ghana: demonstrating the need for population based cancer registries in low and middle-income countries. Journal of global oncology. 2017; 3(6):765-772. [Google Scholar][Crossref]
  64. Trimble EL. Breast cancer in sub -Saharan Africa. Journal of global oncology. 2017; 3(3):187. [Google Scholar][Crossref]
  65. Ukwenya AY, Yusufu LMD, Nmadu PT, Garba ES, Ahmed A. Delayed treatment of symptomatic breast cancer: the experience from Kaduna, Nigeria. South International Journal of Medical and All Body Health Research www.allmedicaljournal.com African Journal of Surgery. 2008; 46(4):106-110. [Google Scholar][Crossref]
  66. Vahabi M, Lofters A, Kumar M, Glazier RH. Breast cancer screening disparities among urban immigrants: a population-based study in Ontario, Canada. BMC Public Health. 2015; 15(1):1-12. [Google Scholar][Crossref]
  67. Vorobiof DA, Sitas F, Vorobiof G. Breast cancer incidence in South Africa. Journal of clinical oncology. 2001; 19(18; SUPP):125-125. [Google Scholar][Crossref]
  68. World Health Organization. Latest world cancer statistics. Geneva: International Agency for Research in Cancer, 2013. [Google Scholar][Crossref]
  69. World Health Organization. Planning and developing population-based cancer registration in low-and middle-income settings: IARC (International Agency for Research on Cancer, 2021. [Google Scholar][Crossref]

How to Cite

Goodluck, A., & P, M. H. (2022). Epidemiology of breast Cancer in Africa: Incidence, Prevalence and Dermographic Variables. International Journal of Medical and All Body Health Research, 3(3), 01-07.

Goodluck, Azuonwu, and Masa Happiness P. "Epidemiology of breast Cancer in Africa: Incidence, Prevalence and Dermographic Variables." International Journal of Medical and All Body Health Research, vol. 3, no. 3, 2022, pp. 01-07.

Goodluck, A. and P, M. H. (2022) 'Epidemiology of breast Cancer in Africa: Incidence, Prevalence and Dermographic Variables', International Journal of Medical and All Body Health Research, 3(3), pp. 01-07.

Goodluck A, P MH. Epidemiology of breast Cancer in Africa: Incidence, Prevalence and Dermographic Variables. International Journal of Medical and All Body Health Research. 2022;3(3):01-07.

Similar Articles

Share

Find this Article on

Google Scholar Semantic Scholar OpenAlex ResearchGate BASE

A newly published article may take a few days to appear on these services.